Moreover, NR2E3 expression was found to be diminished in tumor tissues and reduced with tumor stage progression, not only in HCC but also in multiple tumor types when we analyze TCGA data (Figure S1, Supporting information). The gene discussed is NR2E3; the disease is neoplasm.